News

BÜHLMANN Laboratories AG today announced the appointment of Eric Hrimech to the newly created position of global Chief Commercial Officer (CCO).

BÜHLMANN Laboratories AG announced the appointment of Christian Eberle as its new CEO.

Thanks for connecting with us at ECCO 2025 in Berlin! We enjoyed discussing how IBDoc® and Quantum Blue® are advancing IBD care.

We are pleased to announce that a new edition of our VOX BÜHLMANN is out now.